Beacon Pharmaceuticals Limited IPO Lottery Result (2010)
Beacon Pharmaceuticals Limited IPO Lottery Result will be published as soon as possible after the lottery draw.
Beacon Pharmaceuticals Limited IPO Lottery Result will be available soon after the lottery draw
Beacon Pharmaceuticals Limited IPO Lottery Result Details,
Beacon Pharmaceuticals Limited IPO Lottery Result Bank code and RAK Beacon Pharmaceuticals Limited IPO Lottery refund warrant date and RAK Beacon Pharmaceuticals Limited IPO allotment date and location.
Beacon Pharmaceuticals Limited IPO Lottery Result : Bank / Branch Code
Beacon Pharmaceuticals Limited IPO Lottery Result : Other than NRB (General Public)
Beacon Pharmaceuticals Limited IPO Lottery Result : Mutual Fund
Beacon Pharmaceuticals Limited IPO Lottery Result : Non - Resident Bangladeshi (NRB)
Beacon Pharmaceuticals Limited IPO : Distribution of Refund Warrant
so please visit here to know Beacon Pharmaceuticals Limited IPO Lottery Result
Beacon Pharmaceuticals Limited IPO Lottery Result will be pulished ASAP after the lottery draw.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Beacon Pharmaceuticals Limited IPO Lottery Result (2010)
Beacon Pharmaceuticals Limited IPO Lottery Result will be published as soon as possible after the lottery draw.
Beacon Pharmaceuticals Limited IPO Lottery Result will be available soon after the lottery draw
Beacon Pharmaceuticals Limited IPO Lottery Result Details,
Beacon Pharmaceuticals Limited IPO Lottery Result Bank code and RAK Beacon Pharmaceuticals Limited IPO Lottery refund warrant date and RAK Beacon Pharmaceuticals Limited IPO allotment date and location.
Beacon Pharmaceuticals Limited IPO Lottery date: Please Wait
Beacon Pharmaceuticals Limited IPO Lottery Result : Bank / Branch Code
Beacon Pharmaceuticals Limited IPO Lottery Result : Other than NRB (General Public)
Beacon Pharmaceuticals Limited IPO Lottery Result : Mutual Fund
Beacon Pharmaceuticals Limited IPO Lottery Result : Non - Resident Bangladeshi (NRB)
Beacon Pharmaceuticals Limited IPO : Distribution of Refund Warrant
so please visit here to know Beacon Pharmaceuticals Limited IPO Lottery Result
Beacon Pharmaceuticals Limited IPO Lottery Result will be pulished ASAP after the lottery draw.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Beacon Pharmaceuticals Limited IPO Lottery Result (2010)
Beacon Pharmaceuticals Limited IPO Lottery Result will be published as soon as possible after the lottery draw.
Beacon Pharmaceuticals Limited IPO Lottery Result will be available soon after the lottery draw
Beacon Pharmaceuticals Limited IPO Lottery Result Details,
Beacon Pharmaceuticals Limited IPO Lottery Result Bank code and RAK Beacon Pharmaceuticals Limited IPO Lottery refund warrant date and RAK Beacon Pharmaceuticals Limited IPO allotment date and location.
Beacon Pharmaceuticals Limited IPO Lottery date: Please Wait
Beacon Pharmaceuticals Limited IPO Lottery Result : Bank / Branch Code
Beacon Pharmaceuticals Limited IPO Lottery Result : Other than NRB (General Public)
Beacon Pharmaceuticals Limited IPO Lottery Result : Mutual Fund
Beacon Pharmaceuticals Limited IPO Lottery Result : Non - Resident Bangladeshi (NRB)
Beacon Pharmaceuticals Limited IPO : Distribution of Refund Warrant
so please visit here to know Beacon Pharmaceuticals Limited IPO Lottery Result
Beacon Pharmaceuticals Limited IPO Lottery Result will be pulished ASAP after the lottery draw.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Beacon Pharmaceuticals Limited IPO Lottery Result (2010)
Beacon Pharmaceuticals Limited IPO Lottery Result will be published as soon as possible after the lottery draw.
Beacon Pharmaceuticals Limited IPO Lottery Result will be available soon after the lottery draw
Beacon Pharmaceuticals Limited IPO Lottery Result Details,
Beacon Pharmaceuticals Limited IPO Lottery Result Bank code and RAK Beacon Pharmaceuticals Limited IPO Lottery refund warrant date and RAK Beacon Pharmaceuticals Limited IPO allotment date and location.
Beacon Pharmaceuticals Limited IPO Lottery date: Please Wait
Beacon Pharmaceuticals Limited IPO Lottery Result : Bank / Branch Code
Beacon Pharmaceuticals Limited IPO Lottery Result : Other than NRB (General Public)
Beacon Pharmaceuticals Limited IPO Lottery Result : Mutual Fund
Beacon Pharmaceuticals Limited IPO Lottery Result : Non - Resident Bangladeshi (NRB)
Beacon Pharmaceuticals Limited IPO : Distribution of Refund Warrant
so please visit here to know Beacon Pharmaceuticals Limited IPO Lottery Result
Beacon Pharmaceuticals Limited IPO Lottery Result will be pulished ASAP after the lottery draw.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Based in Bangladesh Beacon Pharmaceuticals Ltd. is one of the finest pharmaceuticals manufacturing facilities to be found any where in the world. It is a centrally monitored fully automated plant with the help of integrated Building Management System (BMS) of USA . Spread over a huge 15 acres of land and having more than 150,000 sft covered areas, the US $ 30 million manufacturing complex has been designed by a reputed European pharmaceuticals consultant. The facilities have been created in order to comply international regulatory requirements like FDA - USA, MHRA - UK, TGA - Australia and GMP - WHO. Backed by a strong R&D set-up Beacon will manufacture specialized drugs in therapy areas like Cancer diseases, Hormone therapies, Cardio-vascular and chronic care diseases. With its cutting edge state-of -the-art facilitiesBeacon is committed to improve the health and quality of life of patients across the world.
Beacon means the light which serves as guide. It helps ocean going vessels to find ways during the darkness of night. Beacon Pharmaceuticals Ltd. with its world class products and services will act as a light for saving lives from life threatening conditions like cancer, heart, liver, kindey and other diseases. It will show the ray of light to ailing patients to live a healthy longer life in this beautiful world. Beacon stands for light for life.
Beacon Pharmaceuticals Limited
Beacon Pharmaceuticals Limited Nature of Business:
The Company is engaged in manufacturing andmarketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitechlyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
Beacon Pharmaceuticals Limited Subscription Open : June 20, 2010
Beacon Pharmaceuticals Limited Subscription Close : June 24, 2010
Beacon Pharmaceuticals Limited For Non-Resident Bangladeshi June 20, 2010 to July 03, 2010
Beacon Pharmaceuticals Limited Reason for IPO To meet the working capital requirement.
Beacon Pharmaceuticals Limited Offer Price Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Face Value Per Share Tk. 10.00
Beacon Pharmaceuticals Limited Market Lot (Shares) : 500
Beacon Pharmaceuticals Limited Pre-IPO Paid-up Capital : Tk.
1,900,000,000.00
Beacon Pharmaceuticals Limited Public Offer (Shares): 30,000,000
Beacon Pharmaceuticals Limited Total Issued Shares (after IPO) : 220,000,000
Beacon Pharmaceuticals Limited Total Paid-up Capital (after IPO) Tk. 2,200,000,000.00
Beacon Pharmaceuticals Limited EPS (as per Prospectus) Tk. 0.31 (as on 30.06.2009)
Beacon Pharmaceuticals Limited NAV Per Share (after revaluation;as per Prospectus) : Tk.16.05 (as on 30.06.2009)
Beacon Pharmaceuticals Limited Issue Manager: ICB Capital Management Limited
Beacon Pharmaceuticals Limited Co-Issue Manager: Janata Bank Limited
Application Document Available atSE & CSE Library, DSE Members House, IssueManagers, Underwriter and Designated Banks.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment